drugset / Trial / NCT01919554

Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents

NCT01919554 ↗

Phase 1 Completed 37 enrolled Stallergenes Greer Syneos Health · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the safety and tolerability of different doses of sublingual tablets of house dust mite (HDM) allergen extracts in adolescents with house dust mite-associated allergic rhinitis.

Timeline

Start
2013-07
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject house dust mites allergen extract Other / unclassified 500 unknown Other
Subject house dust mites allergen extract Other / unclassified 1000 unknown Other
Subject house dust mites allergen extract Other / unclassified 1500 unknown Other

Indications